Tuberculosis Screening Gaps Persist in New DMARD Users

Source link :

TOPLINE: The rates of screening for latent tuberculosis remain suboptimal among new users of biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs), with notable variations by medication type and demographic characteristics. METHODOLOGY: Professional society guidelines recommend screening for tuberculosis before starting treatment with most b/tsDMARDs. In an attempt to estimate the extent of latent tuberculosis […]

Author : News Health

Publish date : 2024-04-02 12:11:11

Copyright for syndicated content belongs to the linked Source.